After an incredible week that saw shares of Peregrine Pharmaceuticals (NASDAQ: PPHM) appreciate a surprising 80% on Monday, shares of this biotech took a 10% haircut today. Why the drop? In this video, health care analyst Max Macaluso discusses today's decline and offers his opinion of what investors should watch in the coming weeks.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.